Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.

Th1 cell induction in lymph nodes according to a red-blue chemokine map.

Matloubian M, Cyster JG.

Immunity. 2012 Dec 14;37(6):954-6. doi: 10.1016/j.immuni.2012.11.007.

PMID:
23244716
[PubMed]
Free PMC Article
2.

CXCR3 is induced early on the pathway of CD4+ T cell differentiation and bridges central and peripheral functions.

Rabin RL, Alston MA, Sircus JC, Knollmann-Ritschel B, Moratz C, Ngo D, Farber JM.

J Immunol. 2003 Sep 15;171(6):2812-24.

PMID:
12960302
[PubMed - indexed for MEDLINE]
Free Article
3.

Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes.

Kawada K, Hosogi H, Sonoshita M, Sakashita H, Manabe T, Shimahara Y, Sakai Y, Takabayashi A, Oshima M, Taketo MM.

Oncogene. 2007 Jul 12;26(32):4679-88. Epub 2007 Feb 5.

PMID:
17297455
[PubMed - indexed for MEDLINE]
4.

CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.

Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, Velden J, Hopfer H, Fehr S, Krieger T, Meyer-Schwesinger C, Meyer TN, Helmchen U, Mittrücker HW, Stahl RA, Panzer U.

J Immunol. 2009 Oct 1;183(7):4693-704. doi: 10.4049/jimmunol.0802626. Epub 2009 Sep 4.

PMID:
19734217
[PubMed - indexed for MEDLINE]
Free Article
5.

Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming.

Martín-Fontecha A, Thomsen LL, Brett S, Gerard C, Lipp M, Lanzavecchia A, Sallusto F.

Nat Immunol. 2004 Dec;5(12):1260-5. Epub 2004 Nov 7.

PMID:
15531883
[PubMed - indexed for MEDLINE]
Free Article
6.

Association between the expression of chemokine receptors CCR7 and CXCR3, and lymph node metastatic potential in lung adenocarcinoma.

Maekawa S, Iwasaki A, Shirakusa T, Kawakami T, Yanagisawa J, Tanaka T, Shibaguchi H, Kinugasa T, Kuroki M, Kuroki M.

Oncol Rep. 2008 Jun;19(6):1461-8.

PMID:
18497951
[PubMed - indexed for MEDLINE]
7.

Expression of rat I-TAC/CXCL11/SCYA11 during central nervous system inflammation: comparison with other CXCR3 ligands.

McColl SR, Mahalingam S, Staykova M, Tylaska LA, Fisher KE, Strick CA, Gladue RP, Neote KS, Willenborg DO.

Lab Invest. 2004 Nov;84(11):1418-29.

PMID:
15322564
[PubMed - indexed for MEDLINE]
Free Article
8.

Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes.

Kawada K, Sonoshita M, Sakashita H, Takabayashi A, Yamaoka Y, Manabe T, Inaba K, Minato N, Oshima M, Taketo MM.

Cancer Res. 2004 Jun 1;64(11):4010-7.

PMID:
15173015
[PubMed - indexed for MEDLINE]
Free Article
9.
10.

Induction of surface CCR4 and its functionality in mouse Th2 cells is regulated differently during Th2 development.

Morimoto Y, Bian Y, Gao P, Yashiro-Ohtani Y, Zhou XY, Ono S, Nakahara H, Kogo M, Hamaoka T, Fujiwara H.

J Leukoc Biol. 2005 Sep;78(3):753-61.

PMID:
16126843
[PubMed - indexed for MEDLINE]
Free Article
11.

Neutralization of IFN-inducible protein 10/CXCL10 exacerbates experimental autoimmune encephalomyelitis.

Narumi S, Kaburaki T, Yoneyama H, Iwamura H, Kobayashi Y, Matsushima K.

Eur J Immunol. 2002 Jun;32(6):1784-91.

PMID:
12115662
[PubMed - indexed for MEDLINE]
12.

In situ leukemic plasmacytoid dendritic cells pattern of chemokine receptors expression and in vitro migratory response.

Bendriss-Vermare N, Chaperot L, Peoc'h M, Vanbervliet B, Jacob MC, Briere F, Bensa JC, Caux C, Plumas J.

Leukemia. 2004 Sep;18(9):1491-8.

PMID:
15284853
[PubMed - indexed for MEDLINE]
13.

Roles for CXC chemokine ligands 10 and 11 in recruiting CD4+ T cells to HIV-1-infected monocyte-derived macrophages, dendritic cells, and lymph nodes.

Foley JF, Yu CR, Solow R, Yacobucci M, Peden KW, Farber JM.

J Immunol. 2005 Apr 15;174(8):4892-900.

PMID:
15814716
[PubMed - indexed for MEDLINE]
Free Article
14.

CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodes.

Hirao M, Onai N, Hiroishi K, Watkins SC, Matsushima K, Robbins PD, Lotze MT, Tahara H.

Cancer Res. 2000 Apr 15;60(8):2209-17.

PMID:
10786686
[PubMed - indexed for MEDLINE]
Free Article
15.

CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions.

Balashov KE, Rottman JB, Weiner HL, Hancock WW.

Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6873-8.

PMID:
10359806
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12.

Vanbervliet B, Bendriss-Vermare N, Massacrier C, Homey B, de Bouteiller O, Brière F, Trinchieri G, Caux C.

J Exp Med. 2003 Sep 1;198(5):823-30.

PMID:
12953097
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The lung cytokine microenvironment influences molecular events in the lymph nodes during Th1 and Th2 respiratory mucosal sensitization to antigen in vivo.

Ritz SA, Cundall MJ, Gajewska BU, Swirski FK, Wiley RE, Alvarez D, Coyle AJ, Stampfli MR, Jordana M.

Clin Exp Immunol. 2004 Nov;138(2):213-20.

PMID:
15498029
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Targeting of Th1-associated chemokine receptors CXCR3 and CCR5 as therapeutic strategy for inflammatory diseases.

Turner JE, Steinmetz OM, Stahl RA, Panzer U.

Mini Rev Med Chem. 2007 Nov;7(11):1089-96. Review.

PMID:
18045212
[PubMed - indexed for MEDLINE]
19.

Selective recruitment of CXCR3+ and CCR5+ CCR4+ T cells into synovial tissue in patients with rheumatoid arthritis.

Norii M, Yamamura M, Iwahashi M, Ueno A, Yamana J, Makino H.

Acta Med Okayama. 2006 Jun;60(3):149-57.

PMID:
16838043
[PubMed - indexed for MEDLINE]
Free Article
20.

Acceleration of diabetes development in CXC chemokine receptor 3 (CXCR3)-deficient NOD mice.

Yamada Y, Okubo Y, Shimada A, Oikawa Y, Yamada S, Narumi S, Matsushima K, Itoh H.

Diabetologia. 2012 Aug;55(8):2238-45. doi: 10.1007/s00125-012-2547-8. Epub 2012 Apr 11.

PMID:
22487925
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk